The digital currency MCAN coin was used to acquire a company that produces certified medical devices to combat the CORONAVIRUS.

The Issuer announces to the public that on August 4, 2020, it concluded an agreement to purchase 1,305,000 registered shares of RED PHARMA LABORATORIES POLSKA S.A. Under the agreement, the ownership of shares constituting 22.5% of the total share capital was effectively transferred, obtaining a proportionate number of votes at the General Meeting of Shareholders.
The price of the purchased shares using the MCAN digital currency was 501,923 MCAN coins and was paid on 05/08/2020. at the rate of 0.07 USD (t).
RED PHARMA LABORATORIES POLSKA S.A. — a company operating on the Polish and European pharmaceutical market. Currently, it offers 9 certified products — designed to fight KORONAVIRUS.
Medical devices class 1, registered in URPL (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products).
Biocidal products, registered in the RRPL (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products).
Antibacterial gels CPNP 3297205 — EU registration in CPNP — Cosmetic Product Notification Portal — showing effective anti-COVID-19 activity.
Certified products available from RED PHARMA LABORATORIES POLSKA S.A. from the AntyCovid-19 line along with the product registration numbers in URPL and CPNP:

1. Medical masks ID 0075 5680 0125 *
2. Medical masks JUNIOR ID 7647 0593 3283 *
3. Disposable hygienic protective aprons ID 9819 0012 9861 *
4. Disposable protective aprons ID 3111 1971 5254 *
5. Disposable beret caps ID 8642 9435 5849 *
6. Protective caps, disposable cap type ID 3119 1793 8518 *
7. Hand disinfectants 0337 / TP / 2020 **
8. Surface disinfectants 1506 / TP / 2020 **
9. Antibacterial gels CPNP 3297205 ***

• class 1 medical device, URPL registration (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products)
  ** biocidal product, registration in RRPL (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products)
  *** EU registration in CPNP — Cosmetic Product Notification Portal
  BLACK PEARL S.A. intends to increase its involvement to a minimum of 30% of the share capital of RED PHARMA LABORATORIES POLSKA S.A. before the end of 2020.
  The reason for introducing RED PHARMA LABORATORIES POLSKA S.A. to the assets of BLACK PEARL S.A. is the consent of the Management Board of the acquired company to sell its products using the virtual currency MCAN coin, owned by the Issuer in the amount of approximately 4.9 billion pieces.
  In the event of a global pandemic, the Management Board of BLACK PEARL S.A. is interested in the acquisition of biochemical and pharmaceutical companies producing substances used to provide anti-COVID-19 protection.